Abstract
West Nile virus (WNV), a mosquito-borne neurotropic flavivirus, has become the leading cause of vector-borne viral encephalitis in the United States for the past decades. The murine model of WNV infection is an effective in vivo experimental model to investigate WNV neuropathogenesis in humans. Here, we describe several laboratory protocols to study WNV infection and the virus-induced inflammation in the brain in both in vitro and in vivo murine models.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Carson PJ, Konewko P, Wold KS et al (2006) Long-term clinical and neuropsychological outcomes of West Nile virus infection. Clin Infect Dis 43(6):723–730. https://doi.org/10.1086/506939
Ou AC, Ratard RC (2005) One-year sequelae in patients with West Nile virus encephalitis and meningitis in Louisiana. J La State Med Soc 157(1):42–46
Sadek JR, Pergam SA, Harrington JA et al (2010) Persistent neuropsychological impairment associated with West Nile virus infection. J Clin Exp Neuropsychol 32(1):81–87. https://doi.org/10.1080/13803390902881918
Nash D, Mostashari F, Fine A et al (2001) The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 344(24):1807–1814
Petersen LR, Brault AC, Nasci RS (2013) West Nile virus: review of the literature. JAMA 310(3):308–315. https://doi.org/10.1001/jama.2013.8042
Beasley DW, Li L, Suderman MT et al (2002) Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology 296(1):17–23. https://doi.org/10.1006/viro.2002.1372
Samuel MA, Diamond MS (2006) Pathogenesis of West Nile virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J Virol 80(19):9349–9360. https://doi.org/10.1128/JVI.01122-06
Arjona A, Foellmer HG, Town T et al (2007) Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. J Clin Invest 117(10):3059–3066. https://doi.org/10.1172/JCI32218
Daniels BP, Holman DW, Cruz-Orengo L et al (2014) Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals. MBio 5(5):e01476–e01414. https://doi.org/10.1128/mBio.01476-14
Wang T, Town T, Alexopoulou L et al (2004) Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10(12):1366–1373. https://doi.org/10.1038/nm1140
Zhang B, Patel J, Croyle M et al (2010) TNF-alpha-dependent regulation of CXCR3 expression modulates neuronal survival during West Nile virus encephalitis. J Neuroimmunol 224(1–2):28–38. https://doi.org/10.1016/j.jneuroim.2010.05.003
Quick ED, Leser JS, Clarke P et al (2014) Activation of intrinsic immune responses and microglial phagocytosis in an ex vivo spinal cord slice culture model of West Nile virus infection. J Virol 88(22):13005–13014. https://doi.org/10.1128/jvi.01994-14
Shrestha B, Gottlieb D, Diamond MS (2003) Infection and injury of neurons by West Nile encephalitis virus. J Virol 77(24):13203–13213. https://doi.org/10.1128/jvi.77.24.13203-13213.2003
Luo H, Winkelmann ER, Zhu S et al (2018) Peli1 facilitates virus replication and promotes neuroinflammation during West Nile virus infection. J Clin Invest 128(11):4980–4991. https://doi.org/10.1172/JCI99902
Parquet MC, Kumatori A, Hasebe F et al (2001) West Nile virus-induced bax-dependent apoptosis. FEBS Lett 500(1–2):17–24. https://doi.org/10.1016/s0014-5793(01)02573-x
Brehin AC, Mouries J, Frenkiel MP et al (2008) Dynamics of immune cell recruitment during West Nile encephalitis and identification of a new CD19+B220-BST-2+ leukocyte population. J Immunol 180(10):6760–6767. https://doi.org/10.4049/jimmunol.180.10.6760
Glass WG, Lim JK, Cholera R et al (2005) Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med 202(8):1087–1098. https://doi.org/10.1084/jem.20042530
Lim JK, Obara CJ, Rivollier A et al (2011) Chemokine receptor Ccr2 is critical for monocyte accumulation and survival in West Nile virus encephalitis. J Immunol 186(1):471–478. https://doi.org/10.4049/jimmunol.1003003
Sitati E, McCandless EE, Klein RS et al (2007) CD40-CD40 ligand interactions promote trafficking of CD8+ T cells into the brain and protection against West Nile virus encephalitis. J Virol 81(18):9801–9811. https://doi.org/10.1128/JVI.00941-07
Sitati EM, Diamond MS (2006) CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system. J Virol 80(24):12060–12069. https://doi.org/10.1128/JVI.01650-06
Xiao SY, Guzman H, Zhang H et al (2001) West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis. Emerg Infect Dis 7(4):714–721
Welte T, Aronson J, Gong B et al (2011) Vgamma4+ T cells regulate host immune response to West Nile virus infection. FEMS Immunol Med Microbiol 63(2):183–192. https://doi.org/10.1111/j.1574-695X.2011.00840.x
Maximova OA, Pletnev AG (2018) Flaviviruses and the central nervous system: revisiting neuropathological concepts. Annu Rev Virol 5(1):255–272. https://doi.org/10.1146/annurev-virology-092917-043439
Ghosh Roy S, Sadigh B, Datan E et al (2014) Regulation of cell survival and death during Flavivirus infections. World J Biol Chem 5(2):93–105. https://doi.org/10.4331/wjbc.v5.i2.93
Acknowledgments
This work was supported in part by NIH grants R01 AI127744 (T.W.) and R21 AI140569 (T.W.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Luo, H., Wang, T. (2023). Methods to Study West Nile Virus Infection and the Virus-Induced Inflammation in the Brain in a Murine Model. In: Bai, F. (eds) West Nile Virus. Methods in Molecular Biology, vol 2585. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2760-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2760-0_6
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2759-4
Online ISBN: 978-1-0716-2760-0
eBook Packages: Springer Protocols